Literature DB >> 8086546

Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia.

J Galofré1, A Moreno, J Mensa, J M Miró, J M Gatell, M Almela, X Claramonte, L Lozano, A Trilla, J Mallolas.   

Abstract

One-hundred seventy-two consecutive adult patients with salmonella bacteremia documented by at least one positive blood culture were prospectively evaluated over a 10-year period. Salmonella enteritidis was isolated in 121 cases (70.3%), Salmonella typhimurium in 29 (16.9%), and other Salmonella species in 22 (12.8%). Twenty-seven patients (15.7%) developed septic metastasis; 21 patients (12.2%) died of bacteremia, and 24 (16.7%) of the 144 patients who survived had at least one relapse. A logistic regression analysis selected three variables as independently influencing outcome: septic shock (P = .005), coma (P = .029), and immunosuppression (P = .04). By means of the same statistical analysis, leukopenia (a white blood cell count of < 4 x 10(9)/L) was identified as an independent risk factor for relapse (P < .0001). The possibility of salmonella bacteremia must be considered when immunosuppressed patients have fever and no obvious source of infection. Treatment with a drug active against Salmonella species is essential in this population. Patients with leukopenia should be considered as recipients of prophylaxis for relapse.

Entities:  

Mesh:

Year:  1994        PMID: 8086546     DOI: 10.1093/clinids/18.6.873

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Salmonella enteritidis primary bacteremia in previously healthy patient from Taiwan: case report.

Authors:  Sevda Mileva; Margarita Gospodinova; Ilian Todorov
Journal:  Ther Adv Infect Dis       Date:  2016-08-30

2.  Coma during Salmonella typhimurium septicaemia.

Authors:  F Leibinger; J M Guerin; A Mofredj
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 3.  Prevertebral neck abscess with Salmonella sandiego: a case presentation and literature review.

Authors:  Gareth Lipton; Theofano Tikka; Hannah Soulsby; Siew Keh
Journal:  BMJ Case Rep       Date:  2019-07-24

4.  Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.

Authors:  Jing Zhao; Jianxin Wei; Nathaniel Weathington; Anastasia M Jacko; Hai Huang; Allan Tsung; Yutong Zhao
Journal:  Transl Res       Date:  2015-01-31       Impact factor: 7.012

5.  An Unusual Case of Septic Arthritis of the Hip.

Authors:  Ujjwayini Ray; Soma Dutta; Arpita Sutradhar
Journal:  J Clin Diagn Res       Date:  2016-11-01

6.  Incidence and prognosis of non-typhoid Salmonella bacteraemia in Denmark: a 10-year county-based follow-up study.

Authors:  K O Gradel; H C Schønheyder; L Pedersen; R W Thomsen; M Nørgaard; H Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

7.  A rabbit model of non-typhoidal Salmonella bacteremia.

Authors:  Aruna Panda; Ivan Tatarov; Billie Jo Masek; Justin Hardick; Annabelle Crusan; Teresa Wakefield; Karen Carroll; Samuel Yang; Yu-Hsiang Hsieh; Michael M Lipsky; Charles G McLeod; Myron M Levine; Richard E Rothman; Charlotte A Gaydos; Louis J DeTolla
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2014-07-03       Impact factor: 2.268

8.  An Unusual Case of Mycotic Popliteal Aneurysm Presenting as Recurrent Salmonella enteritidis Bacteraemia.

Authors:  Shuwei Zheng; Cheng Chuan Lee
Journal:  Eur J Case Rep Intern Med       Date:  2018-02-22

Review 9.  Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.

Authors:  Nicholas A Feasey; Gordon Dougan; Robert A Kingsley; Robert S Heyderman; Melita A Gordon
Journal:  Lancet       Date:  2012-05-14       Impact factor: 79.321

10.  Non-typhoidal Salmonella bacteraemia: epidemiology, clinical characteristics and its' association with severe immunosuppression.

Authors:  Amreeta Dhanoa; Quek Kia Fatt
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-05-18       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.